LTRN
Lantern Pharma Inc. Common Stock
$3.230+-0.000 (-0.000%)
Precio en Tiempo Real
Gráfico de Precios
Loading Chart...
Métricas Clave
Métricas de Mercado
Apertura
$3.230
Máximo
$3.230
Mínimo
$3.230
Volumen
0.11M
Fundamentos de la Empresa
Estadísticas de Negociación
Noticias Relacionadas
BusinessWire
Lantern Pharma Reports First Quarter 2025 Financial Results and Business Updates
Completion of LP-184 Phase 1a clinical trial enrollment with 62-65 patients across a range of solid tumors expected by end of June 2025. Additional patient data readout from the HARMONIC™ Trial evaluating
Ver más
BusinessWire
Lantern Advances Drug Candidate LP-184 with IND Clearance for Phase 1b/2 Clinical Trial in Triple Negative Breast Cancer (TNBC)
The FDA has cleared the investigational new drug (IND) application of LP-184 in triple negative breast cancer (TNBC) treatment – a novel small molecule advanced and developed with Lantern's AI platform,
Ver más
Acciones Relacionadas
Mantente Actualizado
Configura alertas de precio, recibe actualizaciones de análisis de IA y noticias de mercado en tiempo real.